FTI
61
-3
ROST
63
-3
DG
14
-2
IP
50
-6
VIX
22
7
EMN
40
-2
CMA
43
-5
SCHW
37
-3
MTB
38
-3
PX
53
-5
NKE
31
-3
JNJ
32
-6
XRAY
31
-3
VFC
54
-4
BF.B
32
-4
PYPL
49
-3
ZTS
40
-3
AMGN
39
-7
SNA
56
-2
CLX
62
-3
FTI
61
-3
ROST
63
-3
DG
14
-2
IP
50
-6
VIX
22
7
EMN
40
-2
CMA
43
-5
SCHW
37
-3
MTB
38
-3
PX
53
-5
NKE
31
-3
JNJ
32
-6
XRAY
31
-3
VFC
54
-4
BF.B
32
-4
PYPL
49
-3
ZTS
40
-3
AMGN
39
-7
SNA
56
-2
CLX
62
-3
Financhill
Back

Lands' End 10K Form

Sell
37

LE
Lands' End

Last Price:
$13.42
Seasonality Move:
-0.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LE News And Ratings

See the #1 stock for the next 7 days that we like better than LE

LE Financial Statistics

Sales & Book Value

Annual Sales: $1.5B
Cash Flow: $-27.8M
Price / Cash Flow: 7.9
Annual Sales: $7.17
Price / Book: 1.85

Profitability

EPS (TTM): -0.66000
Net Income (TTM): $-20.9M
Gross Margin: $625.5M
Return on Equity: -8.88%
Return on Assets: -2.49%

Lands' End Earnings Forecast

Key Lands' End Financial Ratios

  • The Gross Profit Margin over the past 30 years for LE is 42.48%.
  • The Selling, General & Administrative Expenses for LE have been equal to 37.37% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -36.95% of Operating Income.
  • The Net Earning history of LE is -8.87% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 15 years.

Lands' End Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Specialty Retail
Sector: Consumer Discretionary
Current Symbol: LE
CUSIP: 51509F
Website: landsend.com

Debt

Debt-to-Equity Ratio: 1.34
Current Ratio: 1.74
Quick Ratio: 0.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 22.71

LE Technical Analysis vs Fundamental Analysis

Sell
37
Lands' End (LE) is a Sell

Is Lands' End a Buy or a Sell?

  • Lands' End stock is rated a Sell
    The current Lands' End [LE] share price is $13.40. The Score for LE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.